Search

Siavash K Kurdistani

from Los Angeles, CA
Age ~54
Get Report
Also known as:
Sivash K Kurdistani, Siavash K Kurdistan, Samira K Kordestani, Sivash T, Siavash T, Siavash I, Siamak Kordestani
Phone and address:
1850 Midvale Ave #1, Los Angeles, CA 90025
(310) 749-9686
Related to:
Kurdistani Siavash Khavar
Connected to:
Aimee L Kurdt, 61Mazen S Kurdy, 46Victoria A Kurdyla, 34Fleeta J Kurdys, 76Andrea M Kurdziel, 71Kevin J Kurdziel, 56Patricia R Kurdziel, 69Thomas M Kurdziel, 74Omar M Kure, 59Ronnie R Kure, 68

Siavash Kurdistani Phones & Addresses

  • 1850 Midvale Ave #1, Los Angeles, CA 90025 (310) 749-9686
  • 2101 Camden Ave, Los Angeles, CA 90025
  • Brookline, MA
  • Roxbury Crossing, MA
  • 1850 Midvale Ave APT 1, Los Angeles, CA 90025

Work

Position: Protective Service Occupations

Education

Degree: Bachelor's degree or higher

Resumes

Resumes

Siavash Kurdistani Photo 1

Associate Professor At Ucla

View page
Position:
Assistant Professor at UCLA, Associate Professor at UCLA
Location:
Greater Los Angeles Area
Industry:
Research
Work:
UCLA
Assistant Professor
UCLA since Sep 2004
Associate Professor
Education:
Harvard Medical School 1994 - 1999
Doctor of Medicine (MD) UCLA 1991 - 1994
Bachelor of Science (BS), Biochemistry
Siavash Kurdistani Photo 2

Siavash Kurdistani

View page

Publications

Us Patents

Histone Modification Patterns For Clinical Diagnosis And Prognosis Of Cancer

View page
US Patent:
20120094949, Apr 19, 2012
Filed:
Apr 14, 2010
Appl. No.:
13/262219
Inventors:
David W. Dawson - Pacific Palisades CA, US
Siavash K. Kurdistani - Los Angeles CA, US
David B. Seligson - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/7068
C40B 30/04
A61P 35/00
G01N 33/566
US Classification:
514 49, 435 71, 506 9
Abstract:
The present invention provides methods of diagnosing and providing a prognosis and therapy for cancer including, but not limited to, pancreatic cancer and responsiveness to thymidylate synthase inhibitor (e.g., 5-FU) therapy, by identifying cancers with altered histone modification patterns selected from the group consisting of H3K4me2, H3K9me2, or H3K18ac.

Antibodies Against Histone Modifications For Clinical Diagnosis And Prognosis Of Cancer

View page
US Patent:
20080248039, Oct 9, 2008
Filed:
May 1, 2006
Appl. No.:
11/912429
Inventors:
Siavash K. Kurdistani - Los Angeles CA, US
Michael Grunstein - Los Angeles, CA
David B. Seligson - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 39/395
G01N 33/574
A61P 43/00
US Classification:
4241381, 435 723
Abstract:
The present invention provides methods of diagnosing and providing a prognosis for a cancer by identifying cancers with altered global histone modification patterns using immunohistochemical techniques.
Control profile
Siavash K Kurdistani from Los Angeles, CA, age ~54 Get Report